Upgrades/Downgrades
Updated: 28-Apr-26 16:53 ET
| Upgrades | |||||
| Company | Ticker | Brokerage Firm | Ratings Change | Price Target | |
| IBM | IBM | HSBC Securities | Reduce » Hold | $231 | |
| TFI International | TFII | BofA Securities | Neutral » Buy | $161 | |
| Telus | TU | TD Cowen | Hold » Buy | ||
| Siemens AG | SIEGY | HSBC Securities | Hold » Buy | ||
| Organon | OGN | Piper Sandler | Underweight » Neutral | $14 | |
| Old Dominion | ODFL | Robert W. Baird | Underperform » Neutral | $229 | |
| BW LPG Ltd | BWLP | Kepler | Hold » Buy | ||
|
|
|||||
| Downgrades | |||||
| Company | Ticker | Brokerage Firm | Ratings Change | Price Target | |
| Tronox | TROX | Truist | Hold » Sell | $8 | |
| Rambus | RMBS | Robert W. Baird | Outperform » Neutral | $120 | |
| Nucor | NUE | UBS | Buy » Neutral | $224 | |
| Compass Therapeutics | CMPX | Raymond James | Outperform » Mkt Perform | ||
|
|
|||||
| Coverage Initiated | |||||
| Company | Ticker | Brokerage Firm | Ratings Change | Price Target | |
| Carlisle Cos | CSL | Raymond James | Outperform | $425 | |
| Ultrapar Participacoes | UGP | UBS | Buy | $7 | |
| WEX | WEX | Loop Capital | Buy | $195 | |
| Versigent | VGNT | BNP Paribas Exane | Outperform | $41 | |
| Satellos Bioscience | MSLE | Guggenheim | Buy | $23 | |
| Opus Genetics | IRD | Citizens | Mkt Perform | $12 | |
| Micron | MU | DA Davidson | Buy | $1000 | |
| McKesson | MCK | William Blair | Outperform | ||
| Invitation Homes | INVH | Compass Point | Neutral | $30 | |
| Immatics N.V. | IMTX | TD Cowen | Buy | ||
| Fortis | FTS | Barclays | Overweight | $62 | |
| First Tracks Biotherapeutics | TRAX | H.C. Wainwright | Buy | $30 | |
| Emera | EMA | Barclays | Equal Weight | $53 | |
| Cencora | COR | William Blair | Mkt Perform | ||
| Cardinal Health | CAH | William Blair | Outperform | ||
| American Homes 4 Rent | AMH | Compass Point | Buy | $37.50 | |
| Opendoor Technologies | OPEN | Alliance Global Partners | Buy | $8 | |
| Lineage Cell Therapeutics | LCTX | Canaccord Genuity | Buy | $9 | |
|
|
|||||
| Coverage Resumed | |||||
| Company | Ticker | Brokerage Firm | Ratings Change | Price Target | |
| Enterprises Finl | EFSC | Raymond James | Outperform | $65 | |
|
|
|||||
| Coverage Reiterated/Price Tgt Changed* | |||||
| Company | Ticker | Brokerage Firm | Ratings Change | Price Target | |
| Apple | AAPL | UBS | Neutral | $280 » $287 | |
| Amazon | AMZN | Mizuho | Outperform | $315 » $325 | |
| City Holding Co | CHCO | Hovde Group | Market Perform | $133 » $135 | |
| Lakeland Financial | LKFN | Hovde Group | Market Perform | $63 » $66 | |
| Customers Bancorp | CUBI | Hovde Group | Market Perform | $80 » $86 | |
| Darling Ingredients | DAR | TD Cowen | Buy | $58 » $72 | |
| Microsoft | MSFT | BMO Capital Markets | Outperform | $575 » $505 | |
| TFI International | TFII | TD Cowen | Buy | $130 » $153 | |
|
|
|||||
| (a) Brokerage firm initiating coverage participated in underwriting the recent IPO. |
| (b) Brokerage firm resumes coverage. |
| (c) Brokerage firm participated in the secondary offering. |
| * This list of reiterations/target changes is not comprehensive. |